Tag: SMA type 2 clinical trial

Home / SMA type 2 clinical trial

Categories

Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 2 Patients

GC101 Gene Therapy for Spinal Muscular Atrophy Type 2 – Phase I/II Clinical Trial ClinicalTrials.gov Identifier: NCT05901987Sponsor: GeneCradle Inc.Study Title: Safety and Efficacy of GC101 Gene The...
sma-type-2-clinical-trial

Scan the code